Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Using brain imaging to personalize electric stimulation for treating anhedonia in bipolar depression

Official title: Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression

Run by The University of Texas Health Science Center, Houston · NCT05240352 · Data updated 2026-11-12

This study is testing if a type of brain stimulation can help people with bipolar depression who struggle to feel pleasure and see if it makes a difference in their symptoms.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment45 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedOctober 6, 2022
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedFebruary 18, 2026
Trial IDNCT05240352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with bipolar disorder who exhibit clinically significant anhedonia and mild depressive symptoms.

Probably not a fit

Patients with severe psychiatric conditions, substance abuse issues, or specific contraindications for tDCS may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcranial direct-current stimulation (tDCS) on the brain's reward circuitry in patients with bipolar depression experiencing anhedonia. It aims to determine if tDCS can engage the uncinate fasciculus, a brain tract connecting key regions involved in reward processing, and whether changes in this tract correlate with improvements in anhedonia symptoms. The study will also explore how simulated electric fields may influence these associations. Participants will receive either active or sham tDCS to assess its efficacy.

Why it matters

Potential benefit: If successful, this approach could lead to more effective, personalized treatments for patients suffering from anhedonia associated with bipolar depression.

How similar studies have gone: While the use of tDCS in treating depression has been explored, this specific approach focusing on personalized brain imaging analysis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of Bipolar Disorder and clinically significant anhedonia
* mild symptoms of depression

Exclusion Criteria:

* substance abuse/dependence and any use of drugs (except alcohol or nicotine) in the previous month of the baseline assessment
* participants with personality disorder that would interfere with study participation according to clinical judgment
* previous neurological conditions (epilepsy, traumatic brain injury, stroke, etc)
* any severe, life-threatening non-psychiatric medical condition
* specific contraindications for tDCS (metallic plates in the head)
* Participants identified as acutely suicidal or severely agitated

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.